MedStar Georgetown Cancer Institute | 888-666-3432


Compassionate, Research-Inspired Care

At the MedStar Georgetown Cancer Institute, we recognize clinical trials are transforming how cancer is treated. That’s why Georgetown Lombardi Comprehensive Cancer Center, the Washington, D.C., region’s only National Cancer Institute-designated comprehensive cancer center, serves as our research engine—driving better care. By discovering new and emerging therapies, drugs, and procedures, we can ultimately offer tomorrow’s treatments today—and most importantly, new hope to our patients.

Through our unique partnership, we proudly offer access to:

  • Phase I through IV clinical trials
  • Prevention and control studies, such as tobacco cessation and cancer screening
  • Basic and population science research, translated to the clinic for the benefit of patients

Excellence in cancer care means taking a bench to bedside approach and establishing ongoing collaborations between academic medical centers and community-based programs. 

We encourage you to take an active role in enrolling your patients for these critically important studies.

Offering Tomorrow's Treatments Today 

MedStar Georgetown Cancer Institute combines medical expertise, the latest therapies, and research across the region. With Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C.’s only National Cancer Institute-designated comprehensive cancer center, serving as its research engine, MedStar Georgetown Cancer Institute offers greater access to clinical trials and state-of-the-art technologies closer to where patients live and work. Our nationally recognized oncology specialties and subspecialties cover the full continuum of cancer care—from screening, prevention, research, diagnosis, and treatment, to a personalized rehabilitation program and survivorship support.

Click here to view our six convenient locations.